Fundamental Compounding with Pharmacy Law | April 9 –11, 2026

Taisha Cunningham2026-01-12T08:14:39-06:00December 15th, 2025|Categories: Continuing Education, Compliance, compounding, compounding training, Hazardous drug handling, Pharmaceutical Training, Pharmacist Training, Pharmacy Law, Pharmacy Practice, Pharmacy Technician, Regulatory Issues, USP 795, USP 800|Tags: compounding training, continuing education, news, Pharmacists, Pharmacy Professionals, Pharmacy Technicians, Student Pharmacists|

Fundamental Compounding with Pharmacy Law is a live, multi-day compounding course designed for pharmacists, pharmacy technicians, and pharmacy professionals seeking a strong foundation in both compounding practices and regulatory compliance. This course integrates compounding principles with pharmacy law to support safe, compliant, and high-quality compounding operations.

Participants will review the regulatory framework governing pharmacy compounding, including applicable federal and state considerations and key United States Pharmacopeia (USP) standards. Emphasis is placed on documentation, quality assurance, policies and procedures, and compliance requirements essential to day-to-day compounding practice.

The course includes instruction and hands-on training in common nonsterile dosage forms, such as capsules, molded dosage forms, and topical preparations. Participants will learn proper techniques, equipment use, quality control measures, and best practices to support consistency and patient safety.

A dedicated session on hazardous drug handling addresses requirements for facilities, engineering controls, PPE, and personnel training, with alignment to applicable USP standards and safety expectations.

This program combines didactic instruction and application-based learning to reinforce compounding knowledge, regulatory awareness, and practical skills in a structured, in-person environment.

CLICK HERE TO VIEW FULL ACTIVITY DESCRIPTION

Build a strong foundation in compounding and pharmacy law with this comprehensive, live training designed for pharmacists, pharmacy technicians, and pharmacy professionals. Registration is below.

What attendees said:

“The ACA Fundamentals of Compounding Course was one of the best decisions I’ve made for my pharmacy. The small, hands-on setting, focus on USP 795/800, and opportunity to network with both new and experienced compounders made it invaluable. Highly recommend!”
“The instructor effectively highlighted important topics and used real-world examples to support learning. The small class size made it easy to ask questions and have open discussions.”
“The class was great. The networking with other pharmacists from different areas was great. I was immediately able to take the knowledge learned and apply it in my store.”

Loading...

The American College of Apothecaries (ACA) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACA has accredited this application/certificate-based program for 21 contact hours (2.1 CEUs) of continuing education credit for pharmacists and pharmacy technicians.

Nonsterile Compounding Home Study | 11-Hour PTCB-Recognized CE

Taisha Cunningham2025-12-15T12:49:15-06:00August 20th, 2025|Categories: Continuing Education, Community Pharmacy, Compliance, compounding, compounding training, DEA, FDA, Hazardous drug handling, Home Study, Medication Safety, Patient Care, Patient Safety, Pharmaceutical Training, Pharmacist Training, Pharmacy Law, Pharmacy Practice, Pharmacy Technician, Policies & Procedures, Professional Development, Professional Growth, Regulatory Issues, SOPs, USP 795|Tags: ACA members, Continuing Education Credits, news, Pharmacists, Pharmacy Technicians, Student Pharmacists|

This knowledge-based, enduring home study is designed for compounding pharmacists and pharmacy technicians seeking a comprehensive foundation in nonsterile compounding practices. The program provides a broad overview of nonsterile compounding, with a strong focus on regulatory compliance, standards, dosage forms, and pharmaceutical calculations essential to safe and effective compounding.

Participants will review the regulatory landscape governing nonsterile compounding, including applicable federal and state considerations and key United States Pharmacopeia (USP) standards, with emphasis on USP <795>. The program also addresses the roles and responsibilities of compounding personnel, facility and equipment requirements, documentation, quality assurance, and patient safety considerations.

The curriculum includes in-depth discussions of the most common nonsterile dosage forms prepared by compounders, such as solutions, suspensions, topical preparations, capsules, suppositories, transdermal preparations, and tablet triturates. Each section explores formulation principles, preparation techniques, and quality control measures relevant to practice.

A dedicated pharmaceutical calculations module provides detailed explanations and practical examples to help learners develop proficiency in calculations commonly used in compounding. This module serves as a guide to reinforce accuracy, consistency, and confidence in compounding calculations.

This 11-hour knowledge-based home study is a PTCB-Recognized Education/Training Program, ensuring a quality and standardized learning experience for pharmacy technicians. The program is offered in a self-paced, text-based format and does not include a video component, allowing learners to complete the material on their own schedule.

CLICK HERE TO VIEW FULL ACTIVITY DESCRIPTION

Build a strong foundation in nonsterile compounding and strengthen your skills in compliance, dosage forms, and pharmaceutical calculations—registration is below.

What participants said:

“Covered all of the material in an effective manner.”
“Several topics were covered in detail.”
“I could complete the program at my own pace, which allowed me to take the time needed to fully process and understand the material.”

Note: It is not necessary to create a Lecture Panda account to register for this home study.

The American College of Apothecaries (ACA) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACA has accredited this knowledge-based program for 11 contact hours (1.1 CEUs) of continuing education credit for pharmacists and pharmacy technicians.

2025 American College of Apothecaries Conference & Expo

Taisha Cunningham2025-10-31T02:13:11-05:00April 28th, 2025|Categories: Continuing Education, ACA Fellows Benefit, Administration/Management, Community Pharmacy, Compliance, compounding, DEA, Ethics, FDA, Fellows and Members, Fellows Benefit, Member Benefits, networking, News Release, Pain Management, Patient Care, Patient Safety, Personal Development, Pharmacists, Pharmacy Law, Pharmacy Practice, Pharmacy Technicians, Preceptor/Mentor Training, Professional Development, Professional Growth, Public/Community Health, Regulatory Issues, Revenue, Risk Management, Sports Medicine, Telemedicine / Telepharmacy, USP 795, USP 797, USP 800, Veterinary Compounding, Webinar|Tags: ACA Fellows, ACA members, Healthcare Professionals, news, Pharmacists, Pharmacy Technicians, Student Pharmacists|

It’s time to pack your bags and polish your business cards — the 2025 ACA Annual Conference & Expo is where independent pharmacy meets unforgettable opportunity!

Memphis, TN | September 25–27, 2025

Join us at the legendary Peabody Hotel for the 2025 ACA Annual Conference & Expo — where independent pharmacy professionals come together to connect, learn, and grow.

Your registration includes:

• Continuing Education credit (except guest registration)

• Thursday Night Welcome Reception & Dinner

• All conference meals

• Full access to the exhibition hall

This is your chance to network with pharmacy leaders, discover the latest trends, and showcase your brand in a dynamic, in-person setting. With educational sessions, social events, and all meals included, this is more than a conference — it’s where pharmacy takes care of business!

Speakers Include:

Philip Cowley, PharmD
Kathy Campbell, PharmD
Jessica Beal, PharmD
Jennifer Adams, PharmD, EdD, FAPhA, FNAP
Sue Paul, RPh
L. Michelle Woosley, PharmD, MBA, CMAP

Reserve your spot today and be part of something meaningful!

Register Now

Reservations

The Peabody Memphis – The “South’s Grand Hotel”

The Peabody Memphis is legendary for its charm, elegance, gracious hospitality, and rich history. This Memphis icon, opened in 1869, is listed on the National Register of Historic Places and is world-famous for its five resident Mallard ducks, who march daily through the lobby at 11am and 5pm.

Nestled in the heart of downtown, this AAA Four-Diamond hotel offers a one-of-a-kind experience just blocks from Beale Street, the Memphis Rock ‘n Soul Museum, Fed-Ex Forum, Sun Studio, and the Orpheum Theatre. The Peabody Memphis offers two Restaurants, two Bars, Spa, and a Deli with ice cream and desserts.

THE PEABODY MEMPHIS
149 Union Avenue, Memphis TN 38103

Group Rate: $249 plus taxes and fees
Room Block Deadline: Monday, August 25, 2025, at 5:00 pm CDT

To make your reservations, click the button below or contact Susan Decker, ACA Director of Conferences at 434-989-5938 or susan@acainfo.org.

Individuals will guarantee reservations with a credit card or deposit equal to the first night’s room and tax.

Reserve Now

2025 Sponsors and Exhibitors

Compounding Clarity: Decoding USP Standards in Pharmacy Practice Bundle

Taisha Cunningham2025-10-31T18:15:46-05:00July 27th, 2023|Categories: Continuing Education, compounding, USP 795, USP 797, Veterinary Compounding|Tags: education, news, pharmacist, Pharmacy Technician, student pharmacist, veterinary|

The Compounding Clarity: Decoding USP Standards in Pharmacy Practice Bundle is accredited for 3.0 contact hours (0.3 CEUs) of continuing education credit for pharmacists and pharmacy technicians.

Click Here to Register

Included Webinars:

GFI #256: How it affects compounding for veterinary patients – 2023 / 0.5 CE
This webinar will help veterinary compounders understand the requirements of GFI-256 and why such a document is necessary in the current federal landscape. Pharmacists and technicians will learn when FDA intends to use enforcement discretion regarding the compounding of animal drugs using bulk drug substances and how to comply with these requirements. They will also learn how they can nominate drugs to the list for compounding office stock drugs used for nonfood-producing animals.

Understanding the revision to USP <795> Pharmaceutical Compounding – Nonsterile Preparations – 2023 / 0.5 CE
This webinar will help pharmacists and technicians understand and prepare for changes to USP <795> Pharmaceutical Compounding – Nonsterile Preparations that will go into effect on November 1, 2023. The webinar will include differentiating dosage forms that may be compounded as nonsterile preparations and how to assign beyond-use dates as well as reviewing changes to facility, personnel, and documentation requirements.

Preparing for change: Key aspects of revised USP <797> Pharmaceutical Compounding – Sterile Preparations / 1 CE
This webinar will help pharmacists and technicians understand and prepare for changes to USP <797> Pharmaceutical Compounding – Sterile Preparations that will take effect on November 1, 2023. The webinar will include an overview of requirements including the transition to Category 1, Category 2, and Category 3 compounded sterile preparations and what each of these entails. Topics covered include requirements for facility and equipment, environmental monitoring, personnel training, and competency, documentation, and quality management.

Interpreting and Applying USP Compounded Preparation Monographs in Pharmacy Practice: Recipes for Quality / 1 CE
Since 1820, USP has published Compounded Preparation Monographs (CPMs) with the goal of standardizing quality-assured formulas for the most commonly used compounded preparations for humans and animals. While most pharmacy professionals are aware of these monographs, many do not understand the significance and utility of each of the sections of a monograph. Join this webinar to learn where to find and how to interpret the meaning and intent of these unique “recipes” and how to apply them to your veterinary pharmacy practice.

Thanks to our partnership with the American College of Veterinary Pharmacy

Our Speakers:

Gigi Davidson, RPh, DICVP, FACVP, FSVHP is the former Director of Clinical Pharmacy at the NC State University College of Veterinary Medicine where she practiced veterinary pharmacy for 35 years. Ms. Davidson received a pharmacy degree from UNC-Chapel Hill in 1983 and earned Diplomate status in the International College of Veterinary Pharmacy in 2001. She was inducted into the Phi Zeta Honor Society in 2006 as an honorary member for distinguished advancement of veterinary science. Gigi is a past President of the Society of Veterinary Hospital Pharmacists and of the American College of Veterinary Pharmacists. Ms. Davidson is the ACVP delegate to the American Pharmacists Association House of Delegates. Ms. Davidson was the Chair of the United States Pharmacopeia Compounding Expert Committee from 2010-2020 and continues to serve as a member. Gigi is the recipient of USP’s Beal Award when in 2015 she became the first female and first veterinary recipient of that award. She has many publications in peer-reviewed scientific journals, and her primary area of research interest is the stability, safety, and efficacy of compounded therapies in non-human species. Her research interests in retirement include drug disposition in honey bees and the pharmacological action of plant pollens and nectars on honey bee colonies.

Brenda Jensen CPhT, CNMT, MBA owns Compounding Consultants, LLC in Sioux Falls, SD. She has helped hundreds of compounding facilities across the country improve compounding quality and safety. Brenda is currently president-elect of the American College of Veterinary Pharmacists, serves on the Board of Directors for the American College of Apothecaries Research and Education Foundation, is a peer reviewer for Pharmacy Technician’s Letter, is a member of the APhA House of Delegates, and also teaches compounding courses for the American College of Apothecaries. She was previously the coordinator for the APhA Compounding Special Interest Group and served on the Board of Directors for the International Academy of Compounding Pharmacists and the Pharmacy Compounding Foundation. Brenda began volunteering for USP in 2013 and is currently Chair of the 2020–2025 Compounding Expert Committee.

INDUSTRY UPDATE: USP 795 & Quality Nonsterile Compounds Webinar

Terry Bondurant2025-11-01T05:01:58-05:00September 13th, 2022|Categories: Pharmacy Technician, Pharmacist Training, USP 795|Tags: education, pharmacist|

USP has proposed revisions to chapter <795> which creates minimum standards for compounding of nonsterile dosage forms for both human and animal patients. Attendees will learn about the changes from the current version of USP <795>, highlight key themes in the proposed changes, and prepare themselves to meet or exceed these new standards. In addition, attendees will learn how some the concepts coincide with the FDA’s Insanitary Conditions Guidance document and the role this currently plays in pharmacy practice.

Tuesday, October 11, 2022
12 Noon Eastern / 11:00 am Central / 10:00 am Mountain / 9:00 am Pacific

ACA & ACVP Members: FREE
Non-Members: $20

Learning Objectives:

Define the changes in the proposed USP <795> compared to the current USP <795>
Illustrate the role that personnel and appropriate facilities play in limiting potential contamination of nonsterile compounds.
Analyze the key themes of the proposed USP <795> and how they coincide with the FDA’s Insanitary Conditions Guidance
Plan to implement any changes needed for compliance and quality of nonsterile compounds.

This webinar does not offer CE.

Register below. After you register, you will be directed to Zoom to complete your sign up and receive your Zoom webinar links via email.

Loading…

Matt Martin, PharmD, BCSCP, joined the PCCA Clinical Services team in September 2014 and now serves as Director of Clinical Services. He graduated from Morehead State University with a BS in Chemistry in 2002 and received his PharmD from the University of Kentucky College of Pharmacy in 2006. In 2020, Matt became board certified in Compounded Sterile Preparations through the Board of Pharmacy Specialties. Prior to joining the PCCA team, Matt worked in compounding pharmacy for more than eight years and has experience with both sterile and non-sterile preparations.

ACA’s Response to the Update on USP Compounding Standards

Dana2019-09-25T14:45:00-05:00September 25th, 2019|Categories: News Release, USP 795, USP 797|

On September 23, 2019, ACA received notification that due to ongoing appeals, implementation of proposed changes to USP Chapters 795 and 797 will not occur on December 1, 2019. This is good news for compounding pharmacy: the scope of the revisions to USP Chapters 795 and 797 – and the impact that the current revisions as written would have on maintaining patients’ access to compounded medications and on the preservation of local, independent community pharmacies’ ability to continue to compound—were too great.

ACA is committed to providing compounding training that reflects the USP Chapter Standards. We are in the process of updating the curricula for our 2020 live and online courses to reflect the proposed changes as they are currently written. Once USP makes a decision to deny or remand the ongoing appeals to Chapters 795 and 797, and communicates a new implementation schedule, we will adjust our revisions and training updates accordingly on our website.

If you have any questions about ACA compounding training or the inclusion of USP Chapter Standards in our curricula, please contact us at training@acainfo.org. Click here to read the notice from USP.

Sincerely,

Susan Bartlemay, RPh, FACA, FAPhA
Executive Director | CEO
American College of Apothecaries

Your registration includes:

Speakers Include:

Reservations

2025 Sponsors and Exhibitors

navigation

affiliates

connect

refer a colleague